Hearing Loss Trial, Recruiting NCT05775367 Sponsor: University of North Carolina, Chapel Hill Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT05775367
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For children receiving the cochlear implant (study subjects):

  • A parent or guardian has signed and dated the permission form
  • The child has severe-to-profound hearing loss in one ear only, present from birth or developed before age 2, with normal or near-normal hearing in the other ear
  • The child has not gained enough benefit from hearing aids (based on questionnaire scores or hearing tests showing limited ability to understand speech)
  • The child is between 7 months and 2 years and 11 months old at the time of the implant surgery
  • The child's hearing nerve looks normal on an MRI scan
  • The child's inner ear (cochlea) has no structural abnormalities
  • There is no sign that the hearing in the child's better ear is getting worse over time
  • The child has tried hearing aids as recommended, or is willing to do so
  • Parents understand and can talk about what cochlear implantation can and cannot do — for example, it will not restore fully normal hearing
  • The child has received, or parents are willing to get, recommended meningitis vaccinations as advised by the CDC
  • The child's development and thinking skills are within the normal range based on a standard assessment (DAYC-2)
  • Parents are committed to attending all study appointments, therapy sessions, travel to the study site, and encouraging the child to wear the implant during all waking hours

For comparison group children with one-sided hearing loss (SSD control subjects):

  • A parent or guardian has signed and dated the permission form
  • The child has severe-to-profound hearing loss in one ear from birth or before age 2, with normal or near-normal hearing in the other ear, and cannot benefit from traditional hearing aids
  • The child is 5 years old at the time of testing
  • The child's development and thinking skills are within the normal range based on a standard assessment (Early Stanford Binet 2)

For comparison group children with typical hearing (TH control subjects):

  • A parent or guardian has signed and dated the permission form
  • The child has normal or near-normal hearing in both ears
  • The child is 5 years old at the time of testing
  • The child's development and thinking skills are within the normal range based on a standard assessment (Early Stanford Binet 2)

Who may not be able to join:

For children receiving the cochlear implant (study subjects):

  • English is not the main language spoken at home, as the tests and questionnaires are given in English
  • The child has a type of hearing loss caused by a problem in the middle ear (conductive hearing loss) in either ear
  • The child's cochlear (hearing) nerve is absent or underdeveloped
  • The child's inner ear is blocked by bone or tissue in a way that would prevent implantation
  • The family is unable or unwilling to attend follow-up visits, or lives too far away to do so
  • The child has a history of persistent ear infections that are hard to treat, or a health condition that makes it unsafe to have anesthesia

For comparison group children (control subjects):

  • English is not the main language spoken at home, as the tests and questionnaires are given in English
  • The child or family is unable or unwilling to participate in the required testing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lisa Park, AuD, University of North Carolina, Chapel Hill

Phone: 9842152871

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 July 2023
Est. completion
30 May 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean Difference in the Signal-to-Noise Ratio 50 (SNR-50) between the Study Group and SSD Control Group as Measured with the BKB-SIN at 5 Years of Age; Mean Difference in Localization Error Between the Study Group and the SSD Control group Measured at 5 Years of Age

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov